Beta Blockers, Lp(a), Hypertension, andReduced Basal Fibrinolytic Activity
Open Access
- 1 May 1994
- journal article
- research article
- Published by Elsevier in The American Journal of the Medical Sciences
- Vol. 307 (5), 317-324
- https://doi.org/10.1097/00000441-199405000-00001
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Inheritance conjointly contributing to fibrinolysis and hyperlipidemiaMetabolism, 1993
- Relationships between lipoprotein(a), lipids, apolipoproteins, basal and stimulated fibrinolytic regulators, and d-dimerMetabolism, 1993
- Review: Stratton Lecture. Thrombosis and atherogenesis: molecular connectionsBlood, 1992
- Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.Heart, 1988
- Impaired fibrinolysis in coronary artery diseaseAmerican Heart Journal, 1988
- The extrinsic fibrinolytic system in survivors of myocardial infarctionThrombosis Research, 1987
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980